| 1 | [SID49667970] | Active | AC50 | 0.3 | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 [AID449745, Type: confirmatory] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | AC50 | 0.3 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 | | AID | 449745 | | BioAssay type | confirmatory | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 2 | [SID49667970] | Active | AC50 | 0.3 | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 [AID449745, Type: confirmatory] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | AC50 | 0.3 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 | | AID | 449745 | | BioAssay type | confirmatory | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 3 | [SID49667970] | Active | Potency | 0.3162 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 0.3162 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 4 | [SID49667970] | Active | Potency | 0.3162 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 0.3162 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 5 | [SID49667970] | Active | Potency | 0.7079 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 6 | [SID49667970] | Active | Potency | 0.7943 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Primary screen confirmation [AID2787, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 0.7943 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Primary screen confirmation | | AID | 2787 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 7 | [SID49667970] | Active | Potency | 0.8913 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 8 | [SID49667970] | Active | Potency | 1.122 | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1721, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 1.122 [uM] | | BioAssay | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1721 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 9 | [SID49667970] | Active | Potency | 1.2589 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 1.2589 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 10 | [SID49667970] | Active | Potency | 1.2995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID49667970] | Active | Potency | 1.2995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID49667970] | Active | Potency | 1.2995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID49667970] | Active | Potency | 1.4125 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation [AID2795, Type: confirmatory] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 1.4125 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation | | AID | 2795 | | BioAssay type | confirmatory | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 14 | [SID49667970] | Active | Potency | 1.4125 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation [AID2795, Type: confirmatory] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 1.4125 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation | | AID | 2795 | | BioAssay type | confirmatory | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 15 | [SID49667970] | Active | Potency | 1.5849 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 16 | [SID49667970] | Active | Potency | 1.5849 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 17 | [SID49667970] | Active | EC50 | 2.126 | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. [AID2044, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | EC50 | 2.126 [uM] | | BioAssay | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. | | AID | 2044 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID49667970] | Active | Potency | 2.5929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 2.5929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 19 | [SID49667970] | Active | Potency | 2.5929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 2.5929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID49667970] | Active | Potency | 2.5929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 2.5929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 21 | [SID49667970] | Active | EC50 | 2.777 | Luminescence Cell-Based Dose Response HTS Screen to Identify Cytotoxic Compounds of NIH3T3 cells. [AID2010, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | EC50 | 2.777 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS Screen to Identify Cytotoxic Compounds of NIH3T3 cells. | | AID | 2010 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID49667970] | Active | IC50 | 3.53 | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition [AID588689, Type: confirmatory] | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | IC50 | 3.53 [uM] | | BioAssay | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition | | AID | 588689 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] | | PubMed | | | Data Table |  |
|
| 23 | [SID49667970] | Active | Potency | 3.5481 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 24 | [SID49667970] | Active | Potency | 3.5481 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Rabbit FBPA Selectivity [AID2794, Type: confirmatory] | fructose-bisphosphate aldolase A [Oryctolagus cuniculus] [gi:126722869] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Rabbit FBPA Selectivity | | AID | 2794 | | BioAssay type | confirmatory | | Target | fructose-bisphosphate aldolase A [Oryctolagus cuniculus] [gi:126722869] | | PubMed | | | Data Table |  |
|
| 25 | [SID49667970] | Active | Potency | 3.5481 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Rabbit FBPA Selectivity [AID2794, Type: confirmatory] | fructose-bisphosphate aldolase A [Oryctolagus cuniculus] [gi:126722869] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Rabbit FBPA Selectivity | | AID | 2794 | | BioAssay type | confirmatory | | Target | fructose-bisphosphate aldolase A [Oryctolagus cuniculus] [gi:126722869] | | PubMed | | | Data Table |  |
|
| 26 | [SID49667970] | Active | Potency | 3.6626 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 27 | [SID49667970] | Active | Potency | 3.6626 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 28 | [SID49667970] | Active | Potency | 3.6626 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 29 | [SID49667970] | Active | Potency | 3.6626 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 30 | [SID49667970] | Active | Potency | 4.2284 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 4.2284 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 31 | [SID49667970] | Active | Potency | 4.2284 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 4.2284 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 32 | [SID49667970] | Active | Potency | 4.2284 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 4.2284 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 33 | [SID49667970] | Active | Potency | 4.2284 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 4.2284 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 34 | [SID49667970] | Active | IC50 | 4.971 | Dose Response Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction for Cherry Pick 1 [AID588783, Type: confirmatory] | Arrestin, beta 1 [Homo sapiens] [gi:13177715] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | IC50 | 4.971 [uM] | | BioAssay | Dose Response Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction for Cherry Pick 1 | | AID | 588783 | | BioAssay type | confirmatory | | Target | Arrestin, beta 1 [Homo sapiens] [gi:13177715] | | PubMed | | | Data Table |  |
|
| 35 | [SID49667970] | Active | Potency | 5.6234 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 36 | [SID49667970] | Active | IC50 | 6.06 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | IC50 | 6.06 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 37 | [SID49667970] | Active | Potency | 7.0795 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 38 | [SID49667970] | Active | Potency | 8.1995 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID49667970] | Active | AC50 | 10.22 | POS-1 FP counterscreen Measured in Biochemical System Using Plate Reader - 2024-02_Inhibitor_Dose_CherryPick_Activity_Set2 [AID493130, Type: confirmatory] | POsterior Segregation family member (pos-1) [Caenorhabditis elegans] [gi:17562800] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | AC50 | 10.22 [uM] | | BioAssay | POS-1 FP counterscreen Measured in Biochemical System Using Plate Reader - 2024-02_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 493130 | | BioAssay type | confirmatory | | Target | POsterior Segregation family member (pos-1) [Caenorhabditis elegans] [gi:17562800] | | PubMed | | | Data Table |  |
|
| 40 | [SID49667970] | Active | Potency | 10.3225 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 10.3225 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 41 | [SID49667970] | Active | Potency | 10.3225 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 10.3225 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 42 | [SID49667970] | Active | Potency | 10.3225 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 10.3225 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 43 | [SID49667970] | Active | Potency | 11.2202 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 44 | [SID49667970] | Active | Potency | 11.2202 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 45 | [SID49667970] | Active | Potency | 11.5821 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Cytotoxicity Assay [AID602204, Type: confirmatory] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Cytotoxicity Assay | | AID | 602204 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID49667970] | Active | IC50 | 17.3 | Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) [AID504729, Type: confirmatory] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | IC50 | 17.3 [uM] | | BioAssay | Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 504729 | | BioAssay type | confirmatory | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 47 | [SID49667970] | Active | Potency | 19.9526 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 48 | [SID49667970] | Active | CC50 | 29.54 | Vero Cytoxicity Assay: A Cell Based Secondary Assay to Explore Cytotoxicity of Compounds that Inhibit Flavivirus Genomic Capping Enzyme [AID588742, Type: confirmatory] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | CC50 | 29.54 [uM] | | BioAssay | Vero Cytoxicity Assay: A Cell Based Secondary Assay to Explore Cytotoxicity of Compounds that Inhibit Flavivirus Genomic Capping Enzyme | | AID | 588742 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID49667970] | Active | Potency | 35.4813 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 50 | [SID49667970] | Active | Potency | 35.4813 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49667970 | | CID | 1897383 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|